Publication:
Effect of bone morphogenic protein-2 and desferoxamine on distraction osteogenesis

dc.contributor.authorKalay, Emre
dc.contributor.buuauthorERMUTLU, CENK
dc.contributor.buuauthorYENİGÜL, ALİ ERKAN
dc.contributor.buuauthorYenigül, Ali Erkan
dc.contributor.buuauthorYalçınkaya, Ulviye
dc.contributor.buuauthorYALÇINKAYA, ÜLVİYE
dc.contributor.buuauthorSarısözen, Bartu
dc.contributor.buuauthorSARISÖZEN, MEHMET BARTU
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Ortopedi ve Travmatoloji Anabilim Dalı.
dc.contributor.orcid0000-0003-4071-8052
dc.contributor.researcheridACP-2755-2022
dc.contributor.researcheridAFH-1678-2022
dc.contributor.researcheridABI-7283-2020
dc.contributor.researcheridAEQ-5464-2022
dc.date.accessioned2024-09-13T05:27:40Z
dc.date.available2024-09-13T05:27:40Z
dc.date.issued2022-05-25
dc.description.abstractBackground: Angiogenesis is crucial for formation of a stable regenerate during distraction osteogenesis (DO). This experimental study evaluates if bone morphogenic protein-2 (BMP-2) and desferrioxamine (DFO), two agents which are known to induce neoangiogenesis in vivo , would increase angiogenesis and osteogenesis, and improve mechanical properties of bone regenerate in DO model. Methods: Twenty-four tibias of 24 New Zealand rabbits were osteotomized and fixed with semi-circular fixators. Three groups of 8 animals were formed. BMP-2 soaked scaffolds were used in the first group, whereas daily local DFO injections were made in the second group. Subjects in the control group did not receive any agents during the surgery or in the distraction period. The rabbits in all three groups underwent distraction at a rate of 0.6 mm/day for 15 days following the 7-day latent period. Animals were sacrificed on day 38, and the tibia were harvested for histological and mechanical examination of the regenerate. Results: All 24 rabbits survived the surgical procedure, and there were no side effects against the BMP-2 and local DFO. Three-point bending tests revealed a higher force (361 +/- 267 N.) required for fracture in Group 1 ( p : 0.018). Similarly, the bending moment in Group 1 (5.4 +/- 4.0 Nmm) was significantly higher than the other groups ( p : 0.021). There was no significant difference between the groups in terms of deflection and stiffness ( p > 0.05). Histologically, there was no statistical difference between the groups in terms of endochondral, periosteal, and intramembranous ossification and VEGF activity ( p > 0.05). Conclusion: BMP-2 and DFO stimulate angiogenesis by increasing VEGF activity. Angiogenesis is one of the most important mechanisms for the initiation and maintenance of new bone formation. Stimulation of angiogenesis in unfavorable biomechanical conditions may not be sufficient for ideal bone formation.
dc.identifier.doi10.1016/j.injury.2022.03.064
dc.identifier.endpage1857
dc.identifier.issn0020-1383
dc.identifier.issue6
dc.identifier.startpage1854
dc.identifier.urihttps://doi.org/10.1016/j.injury.2022.03.064
dc.identifier.urihttps://hdl.handle.net/11452/44676
dc.identifier.volume53
dc.identifier.wos000812209300016
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.journalInjury-international Journal Of The Care Of The Injured
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectVascular contribution
dc.subjectEpiphysial cartilage
dc.subjectGene-therapy
dc.subjectAngiogenesis
dc.subjectInhibitors
dc.subjectGrowth
dc.subjectDistraction osteogenesis
dc.subjectDesferoxamine
dc.subjectBone morphogenic protein 2
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectCritical care medicine
dc.subjectEmergency medicine
dc.subjectOrthopedics
dc.subjectSurgery
dc.subjectGeneral & internal medicine
dc.subjectEmergency medicine
dc.subjectOrthopedics
dc.titleEffect of bone morphogenic protein-2 and desferoxamine on distraction osteogenesis
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationce6a66c8-e17a-4463-8a9e-dde91fa90215
relation.isAuthorOfPublication88cde6d8-7aff-42a7-8102-4847acdacd8b
relation.isAuthorOfPublicationda5292e3-7761-4cf8-a4e0-8f9099cf6469
relation.isAuthorOfPublication.latestForDiscoveryce6a66c8-e17a-4463-8a9e-dde91fa90215

Files

Collections